Zobrazeno 1 - 10
of 15
pro vyhledávání: '"M. A. Rusinov"'
Autor:
E. N. Parovichnikova, V. V. Troitskaya, A. N. Sokolov, Z. Kh. Akhmerzaeva, L. A. Kuzmina, L. P. Mendeleeva, G. A. Klyasova, S. K. Kravchenko, Ye. O. Gribanova, S. N. Bondarenko, O. Yu. Baranova, T. S. Kaporskaya, T. V. Ryltsova, A. S. Nizamutdinova, T. P. Zagoskina, Ye. Ye. Zinina, O. S. Samoylova, A. V. Klimovich, Ye. A. Karyakina, A. S. Yelufer’eva, L. V. Gavrilova, T. S. Konstantinova, I. Yu. Toropova, A. S. Pristupa, N. A. Vopilina, T. S. Tikunova, O. P. Skamorina, K. D. Kaplanov, T. N. Obukhova, I. V. Galtseva, M. A. Rusinov, S. M. Kulikov, V. G. Savchenko
Publikováno v:
Онкогематология, Vol 9, Iss 3, Pp 6-15 (2015)
An interim analysis of long-term treatment results for 202 patients with acute lymphoblastic leukemia (ALL), aged 15–60 years, received therapy according protocol ALL-2009 was shown. The basic principle of ALL-2009 was non-aggressive, but continued
Externí odkaz:
https://doaj.org/article/853110f3d74449d98b9b5eb6ad46716e
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 10, Iss 2, Pp 250-257 (2017)
The article provides grounds for a new, expanded definition of a concept «population hematology». It is not only a hematological subsection of the traditional population and epidemiological medicine. It is focused on patients populations as its pri
Autor:
Ryzhko Vv, T V Abramova, L A Grebenyuk, M V Solovyev, V G Savchenko, Elena O. Gribanova, M V Nareyko, M A Rusinov, T N Obukhova, O M Votyakova, Sergei M. Kulikov, L P Mendeleeva, Olga S. Pokrovskaya
Publikováno v:
Терапевтический архив, Vol 89, Iss 7, Pp 32-38 (2017)
To determine the prevalence of amp1q21 and its relationship to the clinical manifestations of multiple myeloma (MM).In December 2009 to March 2016, a total 134 patients aged 30 to 81 years (median 57 years) underwent a pretreatment FISH-study of bone
Autor:
Sergey N. Bondarenko, Valery G. Savchenko, Zalina Akhmerzaeva, Andrey N. Sokolov, Sergei M. Kulikov, Olga Yu Baranova, M A Rusinov, Elena N. Parovichnikova, Larisa A. Kuzmina, Vera V. Troitskaya
Publikováno v:
Blood. 128:5149-5149
Introduction T-cell acute lymphoblastic leukemia (T-ALL) and lymphoma (T-LBL) originate from the common T-cell precursors and are formally differentiated by bone marrow blast count with less than 25% considered as T-LBL. ALL treatment protocols are s
Autor:
Olga Samoilova, Olga A. Gavrilina, A N Sokolov, Sergei M. Kulikov, G M Galstyan, Z Kh Akhmerzaeva, T N Obukhova, Valery G. Savchenko, L V Gavrilova, Irina V. Galtseva, M A Rusinov, Elena O. Gribanova, E E Zinina, G A Baskhaeva, E E Zvonkov, E N Zotina, Elena N. Parovichnikova, G A Klyasova, Sergey N. Bondarenko, T S Kaporskaya, O Yu Baranova, V A Lapin, Vera V. Troitskaya, K D Kaplanov, T S Konstantinova, Larisa A. Kuzmina, Kravchenko Sk
Publikováno v:
Терапевтический архив, Vol 88, Iss 7, Pp 15-24 (2016)
to analyze well-known risk factors (RFs), such as age, immunophenotype, baseline leukocytosis, enhanced lactate dehydrogenase (LDH) activity, time to achieve complete remission, a risk group, and cytogenetic abnormalities) in patients with acute lymp
Autor:
Tatiana Zinina, T S Konstantinova, Tatyana V Ryltzova, Andrey N. Sokolov, Nina Minaeva, Alexandra Eluferieva, Alexandra Klimovich, Tatiana N. Obukhova, Sergey K. Kravchenko, Olga Samoilova, Segey Bondarenko, T S Kaporskaya, Alexander Pristupa, Kliasova Ga, Natalya Vopilina, Olga Yu Baranova, Valeri G. Savchenko, Elena O. Gribanova, L V Gavrilova, Elena N. Parovichnikova, M A Rusinov, Vera V. Troitskaya, Sergei M. Kulikov, Alfiya Nizamutdinova, Tatyana Tikunova, Elena Karyakina, Zalina Akhmerzaeva, V A Lapin, K D Kaplanov, Larisa A. Kuzmina
Publikováno v:
Blood. 126:2497-2497
Introduction It is postulated that the improvement in the overall treatment outcome in adult Ph-negative ALL came from the implementation of more aggressive pediatric-like protocols and higher portion of allogeneic HSCT. Here we report the results of
Autor:
Tatiana N. Obukhova, Vera V. Troitskaya, Sergey M. Kulikov, Alexander Pristupa, Valeri G. Savchenko, T S Konstantinova, Tatyana V Ryltzova, Zalina Akhmerzaeva, Alfiya Nizamutdinova, Elena N. Parovichnikova, Valeri Lapin, Andrey N. Sokolov, Tikunova Ts, Sergey N. Bondarenko, E Karyakina, Anna Klimovich, Sergey K. Kravchenko, G A Klyasova, Tatiana Kaporskaya, A Eluferieva, Larisa A. Kuzmina, Elena O. Gribanova, L V Gavrilova, N A Vopilina, Tamara Pavlovna Zagoskina, M A Rusinov, Olga Samoilova, Olga Yu Baranova, Elena E. Zinina
Publikováno v:
Blood. 124:3662-3662
Introduction Intensive “pediatric oriented” treatment with heavy cytostatic load, incorporation of allogeneic HSCT is now considered a backbone approach in adult ALL therapy. Highly myelosuppressive treatment is more toxic and less reproducible,
Autor:
Olga Samoilova, A N Sokolov, L V Gavrilova, Valery G. Savchenko, T V Gaponova, N V Minaeva, K D Kaplanov, Alexander Pristupa, T S Konstantinova, V A Lapin, E E Zvonkov, Larisa A. Kuzmina, O Yu Baranova, M A Rusinov, Kravchenko Sk, Larisa P. Mendeleeva, A V Klimovich, Sergei M. Kulikov, Sergey N. Bondarenko, Elena N. Parovichnikova, Moskov Vi, Elena O. Gribanova, T S Kaporskaya, Vera V. Troitskaya, Z Kh Akhmerzaeva, T V Obukhova, Irina V. Galtseva, I V Kryuchkova, E A Borisenkova, E E Zinina, T V Ryltsova, G A Klyasova, Alfiya Nizamutdinova
Publikováno v:
Scopus-Elsevier
Терапевтический архив, Vol 87, Iss 7, Pp 15-25 (2015)
Терапевтический архив, Vol 87, Iss 7, Pp 15-25 (2015)
To analyze the efficiency of the ALL-2009 protocol (ClinicalTrials.gov NCT01 193933) in patients with T-cell leukemias, particularly the role of autologous hematopoietic stem cell transplantation (auto-HSCT) after non-myeloablative BEAM conditioning,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08ce172ab691bc6318f423d5d859512e
http://www.scopus.com/inward/record.url?eid=2-s2.0-84942602797&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-84942602797&partnerID=MN8TOARS
Autor:
T V Abramova, T N Obukhova, L P Mendeleeva, O S Pokrovskaya, E O Gribanova, V V Ryzhko, L A Grebenyuk, M V Nareyko, M V Solovyev, O M Votyakova, S M Kulikov, M A Rusinov, V G Savchenko
Publikováno v:
Терапевтический архив, Vol 89, Iss 7, Pp 32-38 (2017)
Aim. To determine the prevalence of amp1q21 and its relationship to the clinical manifestations of multiple myeloma (MM). Subjects and methods. In December 2009 to March 2016, a total 134 patients aged 30 to 81 years (median 57 years) underwent a pre
Externí odkaz:
https://doaj.org/article/7b4e34b526524669a31cc54969d8caac